AstraZeneca PLC feels pinch of generic rival
Article Abstract:
AstraZeneca PLC of the United Kingdom has reduced its financial projection for share earnings for 2006 as a copy of its heart drug Troprol-XL was launched by rival Sandoz. AstraZeneca PLC is planning its own generic version of Troprol-XL.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Diageo's profit declines 22%: premium brands lift sales by 3% in year; forecast is raised
Article Abstract:
Fiscal-year net profit for Diageo PLC dropped 22% to $3 bil in comparison to last year, for which figures were higher due to gains and lower taxes. Sales rose 3%.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: AstraZeneca net and sales surge; cost cuts are set. AstraZeneca posts 15% drop in net. Earnings jump at Glaxo, AstraZeneca
- Abstracts: Fear of commitments at Nissan? Toyota feels pinch along with big 3 as sales dive. Korean car sales increase: high won, labor woes cloud 2007 outlook after December gain
- Abstracts: Friends, Resolution alter voting terms for merger. HBOS, as appetite for debt wanes, aids banking affiliate
- Abstracts: Philips posts surge in net profit. Philips raises profit-margin targets. Medical unit weighs on Philips
- Abstracts: Bharti Airtel net soars on rise in subscribers. Net surges at Hutchison Telecom. France Telecom's domestic business boosts results